Home Cart Sign in  
Chemical Structure| 1093119-54-0 Chemical Structure| 1093119-54-0

Structure of MKC3946
CAS No.: 1093119-54-0

Chemical Structure| 1093119-54-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

MKC3946 is a small-molecule IRE1α endoribonuclease domain inhibitor which can block XBP1 splicing.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of MKC3946

CAS No. :1093119-54-0
Formula : C21H20N2O3S
M.W : 380.46
SMILES Code : O=CC1=C2C=CC(C3=CC=C(C(N4CCN(C)CC4)=O)S3)=CC2=CC=C1O
MDL No. :MFCD30496700
InChI Key :IVQVBMWPWPTSNO-UHFFFAOYSA-N
Pubchem ID :59599728

Safety of MKC3946

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MCF-7:5C 20 μM 72 h Inhibition of IRE1α:XBP1s UPR pathway enhances TTC-352-induced apoptosis PMC7790886
Vascular Smooth Muscle Cells (VSMCs) 40 μM 12 h MKC-3946 significantly reduced the expression of XBP1s, CHOP, ATF6, and ATF4 induced by Ang II, without affecting the expression levels of IRE1α and p-IRE1α. PMC8771832
1.1B4 cells 10 µM 24 h MKC3946 treatment significantly inhibited ER stress-induced hIAPP expression and improved β-cell function. PMC11237843
Mouse bone marrow mesenchymal stem cells 10 nM 24 h Inhibition of Xbp1s formation significantly decreased the expression of osteoblastic differentiation-related molecules induced by bortezomib PMC7708206
MC3T3-E1 cells 10 nM 24 h Inhibition of Xbp1s formation significantly decreased the expression of osteoblastic differentiation-related molecules induced by bortezomib PMC7708206

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Aortic Dissection Model Intraperitoneal injection 100 mg/kg Once daily for 2 weeks MKC-3946 significantly alleviated Ang II-induced aortic dissection formation and medial layer destruction, and reduced ROS production and apoptosis in the aortic wall. PMC8771832
C57BL/KaLwRij mice Five-week old C57BL/KaLwRij mice Intraperitoneal injection 100 mg/kg Once daily for 7 days Inhibition of Xbp1s signaling significantly abolished bortezomib-mediated bone formation PMC7708206

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.63mL

0.53mL

0.26mL

13.14mL

2.63mL

1.31mL

26.28mL

5.26mL

2.63mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories